↓ Skip to main content

Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patients

Overview of attention for article published in European Journal of Cancer (1965), March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
twitter
6 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patients
Published in
European Journal of Cancer (1965), March 2015
DOI 10.1016/j.ejca.2015.01.008
Pubmed ID
Authors

Jalid Sehouli, Christina Fotopoulou, Edibe Erol, Rolf Richter, Alexander Reuss, Sven Mahner, Eric Pujade Lauraine, Gunnar Kristensen, Jörn Herrstedt, Andreas du Bois, Jacobus Pfisterer

Abstract

Alopecia is a common side-effect of chemotherapy and affects quality of life of cancer patients. Some patients and physicians believe that alopecia could be a surrogate marker for response to chemotherapy and impact on prognosis. However, this was never been tested in a sufficiently large cohort of ovarian cancer patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 14%
Student > Ph. D. Student 4 11%
Student > Doctoral Student 3 8%
Other 3 8%
Professor 3 8%
Other 5 14%
Unknown 13 36%
Readers by discipline Count As %
Medicine and Dentistry 10 28%
Nursing and Health Professions 3 8%
Agricultural and Biological Sciences 3 8%
Biochemistry, Genetics and Molecular Biology 2 6%
Psychology 2 6%
Other 3 8%
Unknown 13 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2015.
All research outputs
#2,650,470
of 25,374,917 outputs
Outputs from European Journal of Cancer (1965)
#693
of 6,871 outputs
Outputs of similar age
#32,793
of 274,511 outputs
Outputs of similar age from European Journal of Cancer (1965)
#9
of 52 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,871 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.